
Diversity, Representation, Equity & Advocacy MatterS
DREAMS for Duchenne
Entrada DREAMS is a competitive grants program designed to fund efforts within the Duchenne muscular dystrophy community to better identify, understand and reach those who are currently underrepresented and underserved.
DREAMS and Belonging
Entrada is building a company culture where everyone can belong, contribute and grow. In the same way, we are committed to working toward a healthcare system that is equitable, inclusive and diverse. Entrada DREAMS is part of our commitment to support Duchenne-focused non-profit organizations in their efforts to address discrimination and disparity in healthcare and to better serve all people living with Duchenne.
DREAMS and Giving
In 2023, three grants of $25,000 (USD) each will be awarded to U.S. based non-profit organizations with project proposals that embrace diversity, inclusivity, accessibility and the creation or expansion of vital services to achieve greater equality within the Duchenne community.
Grant Review Committee

Founder, determinence
Podcast Co-Host,
Two Disabled Dudes

CEO & Founder
Girls Chronically Rock

Disability Services Specialist
University of Illinois at Chicago

Pediatric Neurologist
Arkansas Children’s Hospital
Eligibility Requirements
Must be a U.S. based non-profit organization with services for people living with Duchenne muscular dystrophy
Must hold current 501(c)(3) status
Application Requirements
Applications must be concise and approximately three (3) pages in length. Font size ≥ 10
Statement of target demographic and identified community need(s)
A detailed description of the project plan and timeline for implementation
A goal that is clearly outlined, measurable, and attainable
A project budget detailing how proceeds of the grant will be allocated
A commitment to apply grant funding within one-year of receipt and to provide Entrada with a project summary
Only one application per non-profit organization will be considered. A written agreement, defining the basic conditions of the grant, will be entered between Entrada Therapeutics and the award recipients.
Review Criteria
Applications will be judged by an independent review committee comprised of neuromuscular specialists and patient advocates with expertise in Duchenne, Diversity, Equity, Inclusion & Access (DEIA), social impact and health. Each application will be anonymized and reviewed, scored, and ranked using the following criteria:
Inclusivity
Accessible to intended audience (e.g., multilingual, ADA compliant, culturally relevant, etc.)
Informed by minority-led or representative community organization(s)
Reach
Delivers to underserved community(s) where they are
Reproducible in multiple geographies
Addresses needs of multiple underserved groups
Vision
Addresses a clear unmet need
Specific objective and measure of success
Sustainable
Uniqueness
Novel idea or program
Shows commitment to a new way of working to advance DEIA
In addition to meeting the criteria above, applicants are encouraged to demonstrate collaboration with minority-led or local community organizations to overcome barriers that limit the delivery of health education and support for individuals and families in need.
Resources
Organizations seeking guidance to prepare an application may find the resources listed below helpful: